benzyloxycarbonylvalyl-alanyl-aspartyl-fluoromethyl-ketone and nafamostat

Granzyme A (GzmA) was first identified as a cytotoxic T lymphocyte protease protein with limited tissue expression. A number of cellular proteins are known to be cleaved by GzmA, and its function is to induce apoptosis. Histones H1, H2B, and H3 were identified as GzmA substrates during apoptotic cell death. Here, we demonstrated that histone H4 was cleaved by GzmA during staurosporine-induced cell death; however, in the presence of caspase inhibitors, staurosporine-treated Raji cells underwent necroptosis instead of apoptosis. Furthermore, histone H4 cleavage was blocked by the GzmA inhibitor nafamostat mesylate and by GzmA knockdown using siRNA. These results suggest that histone H4 is a novel substrate for GzmA in staurosporine-induced cells. [BMB Reports 2016; 49(10): 560-565].

Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Benzamidines; Blotting, Western; Caspase Inhibitors; Cell Line, Tumor; Flow Cytometry; Granzymes; Guanidines; HEK293 Cells; HeLa Cells; Histones; Humans; Recombinant Proteins; RNA Interference; RNA, Small Interfering; Staurosporine